{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:13:37Z","timestamp":1791389617509,"version":"4.3.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Varicella-zoster virus (VZV) is a known cause of aseptic meningitis, with a predisposition for an immunocompromised population. A dermatomal rash usually accompanies aseptic meningitis secondary to VZV.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report the case of a 31-year-old male with a history of chickenpox in childhood and recent shingles who presented with severe frontal headaches secondary to VZV meningitis. The patient had also recently received the measles-mumps-rubella (MMR) vaccine. He recovered without any neurological sequala.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This case report describes an immunocompetent patient with recent MMR vaccination who developed aseptic meningitis secondary to VZV without any dermatomal involvement (Zoster Sine Herpete).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06453-5","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T05:33:08Z","timestamp":1628832788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Case report: aseptic meningitis secondary to varicella-zoster virus (VZV) without an exanthem post MMR vaccination"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0119-3329","authenticated-orcid":false,"given":"Syeda","family":"Sahra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Jahangir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neville","family":"Mobarakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Jahangir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,3]]},"reference":[{"issue":"7\u20138","key":"6453_CR1","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0264-410X(01)00438-8","volume":"20","author":"SS da Cunha","year":"2002","unstructured":"da Cunha SS, Rodrigues LC, Barreto ML, Dourado I. Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain. Vaccine. 2002;20(7\u20138):1106\u201312. https:\/\/doi.org\/10.1016\/S0264-410X(01)00438-8.","journal-title":"Vaccine"},{"issue":"5","key":"6453_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/oxfordjournals.aje.a010239","volume":"151","author":"I Dourado","year":"2000","unstructured":"Dourado I, Cunha S, Teixeira MG, Farrington CP, Melo A, Lucena R, et al. Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs. Am J Epidemiol. 2000;151(5):524\u201330. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a010239.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"6453_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1590\/S0036-46652001000500012","volume":"43","author":"WO Arruda","year":"2001","unstructured":"Arruda WO, Kondageski C. Aseptic meningitis in a large MMR vaccine campaign (590,609 people) in Curitiba, Paran\u00e1, Brazil, 1998. Rev Inst Med Trop Sao Paulo. 2001;43(5):301\u20132. https:\/\/doi.org\/10.1590\/S0036-46652001000500012.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"2","key":"6453_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/09674845.2016.1159047","volume":"73","author":"S Mamishi","year":"2016","unstructured":"Mamishi S, Sarkardeh M, Pourakbari B, Keshavarz Valian S, Sabouni F, Mahmoudi S. Aseptic meningitis after measles-mumps-rubella (MMR) vaccination. Br J Biomed Sci. 2016;73(2):84\u20136. https:\/\/doi.org\/10.1080\/09674845.2016.1159047.","journal-title":"Br J Biomed Sci"},{"issue":"5","key":"6453_CR5","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/ije\/31.5.978","volume":"31","author":"CM da Silveira","year":"2002","unstructured":"da Silveira CM, Kmetzsch CI, Mohrdieck R, Sperb AF, Prevots DR. The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997. Int J Epidemiol. 2002;31(5):978\u201382. https:\/\/doi.org\/10.1093\/ije\/31.5.978.","journal-title":"Int J Epidemiol"},{"issue":"6","key":"6453_CR6","first-page":"681","volume":"51","author":"E Autret","year":"1996","unstructured":"Autret E, Jonville-B\u00e9ra AP, Galy-Eyraud C, Hessel L. Aseptic meningitis after mumps vaccination. Therapie. 1996;51(6):681\u20133.","journal-title":"Therapie"},{"issue":"1","key":"6453_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/(SICI)1099-1557(199601)5:1<33::AID-PDS210>3.0.CO;2-7","volume":"5","author":"AP Jonville-Bera","year":"1996","unstructured":"Jonville-Bera AP, Autret E, Galy-Eyraud C, Hessel L. Aseptic meningitis following mumps vaccine. A retrospective survey by the French regional pharmacovigilance centres and by Pasteur-M\u00e9rieux S\u00e9rums & Vaccins. Pharmacoepidemiol Drug Saf. 1996;5(1):33\u20137. https:\/\/doi.org\/10.1002\/(SICI)1099-1557(199601)5:1<33::AID-PDS210>3.0.CO;2-7.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"6453_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1442-200X.1996.tb03471.x","volume":"38","author":"M Kimura","year":"1996","unstructured":"Kimura M, Kuno-Sakai H, Yamazaki S, Yamada A, Hishiyama M, Kamiya H, et al. Adverse events associated with MMR vaccines in Japan. Acta Paediatr Jpn. 1996;38(3):205\u201311. https:\/\/doi.org\/10.1111\/j.1442-200X.1996.tb03471.x.","journal-title":"Acta Paediatr Jpn"},{"issue":"5093","key":"6453_CR9","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/bmj.2.5093.418","volume":"2","author":"GW Lewis","year":"1958","unstructured":"Lewis GW. Zoster sine herpete. Br Med J. 1958;2(5093):418\u201321. https:\/\/doi.org\/10.1136\/bmj.2.5093.418.","journal-title":"Br Med J"},{"issue":"9","key":"6453_CR10","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1056\/NEJM200003023420906","volume":"342","author":"DH Gilden","year":"2000","unstructured":"Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med. 2000;342(9):635\u201345. https:\/\/doi.org\/10.1056\/NEJM200003023420906.","journal-title":"N Engl J Med"},{"issue":"22","key":"6453_CR11","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1056\/NEJMp058091","volume":"352","author":"A Arvin","year":"2005","unstructured":"Arvin A. Aging, immunity, and the varicella\u2013zoster virus. N Engl J Med. 2005;352(22):2266\u20137. https:\/\/doi.org\/10.1056\/NEJMp058091.","journal-title":"N Engl J Med"},{"key":"6453_CR12","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.3389\/fmicb.2019.01634","volume":"10","author":"L Laemmle","year":"2019","unstructured":"Laemmle L, Goldstein RS, Kinchington PR. Modeling varicella-zoster virus persistence and reactivation - closer to resolving a perplexing persistent state. Front Microbiol. 2019;10:1634. https:\/\/doi.org\/10.3389\/fmicb.2019.01634.","journal-title":"Front Microbiol"},{"issue":"4","key":"6453_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/INF.0b013e318160ee11","volume":"27","author":"TR Leahy","year":"2008","unstructured":"Leahy TR, Webb DW, Hoey H, Butler KM. Varicella-zoster virus-associated acute aseptic meningitis without exanthem in an immunocompetent 14-year-old boy. Pediatr Infect Dis J. 2008;27(4):362\u20133. https:\/\/doi.org\/10.1097\/INF.0b013e318160ee11.","journal-title":"Pediatr Infect Dis J"},{"key":"6453_CR14","doi-asserted-by":"publisher","first-page":"594","DOI":"10.12659\/AJCR.894045","volume":"16","author":"W Ibrahim","year":"2015","unstructured":"Ibrahim W, Elzouki A-N, Husain A, Osman L. Varicella-zoster aseptic meningitis: report of an atypical case and literature review. Am J Case Rep. 2015;16:594\u20137. https:\/\/doi.org\/10.12659\/AJCR.894045.","journal-title":"Am J Case Rep"},{"issue":"4","key":"6453_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/jmv.1890430403","volume":"43","author":"JM Echevarr\u00eda","year":"1994","unstructured":"Echevarr\u00eda JM, Casas I, Tenorio A, de Ory F, Mart\u00ednez-Mart\u00edn P. Detection of varicella-zoster virus-specific DNA sequences in cerebrospinal fluid from patients with acute aseptic meningitis and no cutaneous lesions. J Med Virol. 1994;43(4):331\u20135. https:\/\/doi.org\/10.1002\/jmv.1890430403.","journal-title":"J Med Virol"},{"issue":"1","key":"6453_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/00006454-200301000-00026","volume":"22","author":"R Jhaveri","year":"2003","unstructured":"Jhaveri R, Sankar R, Yazdani S, Cherry JD. Varicella-zoster virus: an overlooked cause of aseptic meningitis. Pediatr Infect Dis J. 2003;22(1):96\u20137. https:\/\/doi.org\/10.1097\/00006454-200301000-00026.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"6453_CR17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/ana.410290520","volume":"29","author":"AN Dueland","year":"1991","unstructured":"Dueland AN, Devlin M, Martin JR, Mahalingam R, Cohrs R, Manz H, et al. Fatal varicella-zoster virus meningoradiculitis without skin involvement. Ann Neurol. 1991;29(5):569\u201372. https:\/\/doi.org\/10.1002\/ana.410290520.","journal-title":"Ann Neurol"},{"issue":"2","key":"6453_CR18","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1067\/mpd.2002.121934","volume":"140","author":"E Chiappini","year":"2002","unstructured":"Chiappini E, Calabri G, Galli L, Salvi G, de Martino M. Varicella-zoster virus acquired at 4 months of age reactivates at 24 months and causes encephalitis. J Pediatr. 2002;140(2):250\u20131. https:\/\/doi.org\/10.1067\/mpd.2002.121934.","journal-title":"J Pediatr"},{"issue":"2","key":"6453_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/jmv.1890160213","volume":"16","author":"P Mart\u00ednez-Mart\u00edn","year":"1985","unstructured":"Mart\u00ednez-Mart\u00edn P, Garc\u00eda-S\u00e1iz A, Rap\u00fan JL, Echevarr\u00eda JM. Intrathecal synthesis of IgG antibodies to varicella-zoster virus in two cases of acute aseptic meningitis syndrome with no cutaneous lesions. J Med Virol. 1985;16(2):201\u20139. https:\/\/doi.org\/10.1002\/jmv.1890160213.","journal-title":"J Med Virol"},{"issue":"3","key":"6453_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/00006454-199103000-00008","volume":"10","author":"A Sugiura","year":"1991","unstructured":"Sugiura A, Yamada A. Aseptic meningitis as a complication of mumps vaccination. Pediatr Infect Dis J. 1991;10(3):209\u201313. https:\/\/doi.org\/10.1097\/00006454-199103000-00008.","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"6453_CR21","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1128\/CMR.00052-13","volume":"26","author":"AA Gershon","year":"2013","unstructured":"Gershon AA, Gershon MD. Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiol Rev. 2013;26(4):728\u201343. https:\/\/doi.org\/10.1128\/CMR.00052-13.","journal-title":"Clin Microbiol Rev"},{"key":"6453_CR22","doi-asserted-by":"publisher","first-page":"bcr2017223257","DOI":"10.1136\/bcr-2017-223257","volume":"2018","author":"MF Khaliq","year":"2018","unstructured":"Khaliq MF, Kochar T, John M. Varicella-zoster meningitis: an atypical case of zoster reactivation in immunocompetent young adult. BMJ Case Rep. 2018;2018:bcr2017223257.","journal-title":"BMJ Case Rep"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06453-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06453-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06453-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T05:38:43Z","timestamp":1628833123000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06453-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6453"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06453-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,3]]},"assertion":[{"value":"23 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research department reviewed the case report and manuscript. No experimental intervention was performed, and it did not require any specification of guidelines, legislations, or permissions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors contacted the patient and family during the hospital stay and after discharge. We obtained verbal and written consent for the use of patient data, images, CSF studies blood work for the publication of the case for purely educational and research purposes, to which the patient and family agreed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No competing financial or personal interests are involved for all the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"746"}}